Neuromuscular and Neurogenetic Disorders
The clinical research activity is centered on Hereditary Spastic Paraplegia Type 50 (SPG50), a rare neurogenetic disorder affecting motor function and spasticity. The sponsor’s research interest is focused on disease areas involving inherited neurological impairment and targeted molecular correction.
- Hereditary Spastic Paraplegia Type 50
- Motor pathway dysfunction
- Rare inherited neurological disease
The funded study reflects involvement in rare disease care within a hospital-based setting in Bergamo, Italy.
Gene Therapy
Research activity includes interest in gene therapy for a monogenic neurological condition, with attention to restoring function through genetic intervention. The therapeutic domain is centered on AP4M1-related treatment strategies for SPG50.
- AAV9-based gene delivery
- AP4M1 genetic correction
- Inherited CNS disorders
This area places the sponsor within the field of advanced molecular therapies for neurological disease.
Central Nervous System Therapeutics
The sponsor is active in research targeting the central nervous system, particularly conditions involving impaired motor control and progressive spasticity. The clinical focus is on therapeutic approaches intended to address underlying neurological deficits.
- Spasticity disorders
- Upper motor neuron impairment
- Neurological functional restoration
Its research portfolio highlights engagement with specialized hospital neurology and rare neurological disease management.
Rare Disease Clinical Research
The sponsor’s trial activity is concentrated in a rare disease setting, supporting research for a condition with limited therapeutic options. The clinical landscape includes investigation of novel interventions for small patient populations with unmet medical need.
- Orphan neurological disease
- Precision medicine
- Targeted treatment development
Current activity is limited to a single actively recruiting study in one collaborating site, reflecting a focused interest in specialized translational research.
